759 F. Supp. 2d 929
S.D. Ohio2010Background
- Phillips died while using a fentanyl transdermal patch manufactured by ALZA and distributed by Sandoz.
- Miller, as administrator of Phillips's estate, sued for statutory product liability, negligence, misrepresentation, warranties, and punitive damages.
- Patch design allegedly leaks due to seal defects, causing fentanyl overdose despite proper use.
- Treating physician Hale continued prescribing the patch; Phillips had escalating doses prior to death and high postmortem fentanyl levels (13 ng/mL).
- Coroner ruled death from fentanyl intoxication; toxicology and autopsy supported overdose as the cause.
- Court granted in part and denied in part the defendants’ motion for summary judgment, addressing specific product-liability theories under Ohio law.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Failure to warn adequacy | Warnings were inadequate about leakage and overdose risk. | Dr. Hale would have prescribed despite warnings; experts unqualified to testify on warnings. | Summary judgment for ALZA/Sandoz on failure-to-warn claim granted. |
| Design defect viability | Reservoir design risks outweighed benefits; alternatives existed. | Patch not unavoidably unsafe; warnings shield design defect; dispute about pleading sufficiency. | Design defect claim survives; summary judgment denied on design defect. |
| Manufacturing defect sufficiency | Circumstantial evidence supported leaking-patch theory. | No direct evidence of leakage; no manufacturing defect. | Circumstantial evidence creates factual question; summary judgment denied on manufacturing defect. |
| Failure to conform to representations | Patches did not conform to represented fentanyl blood-concentration levels. | No specific representations identified or testified to by experts. | Summary judgment denied; claim survives as to conformity with representations. |
| OPLA warranty and related claims | Warranty claims not barred by OPLA as UCC-based and not common-law. | OPLA abrogates negligence, negligent misrepresentation, and common-law warranty; UCC claims unclear. | Summary judgment granted for negligence, negligent misrepresentation, and common-law warranties; UCC warranty claims properly not maintained; thus some warranty claims barred. |
Key Cases Cited
- Graham v. Am. Cyanamid Co., 350 F.3d 496 (6th Cir. 2003) (as to expert testimony and duty to warn for prescription drugs)
- Seley v. G.D. Searle Co., 67 Ohio St.2d 192 (1981) (proximate causation in failure-to-warn cases in Ohio)
- Wheat v. Pfizer, Inc., 31 F.3d 340 (5th Cir. 1994) (prescription-drug warning causation rule; physician decision impact)
- State Farm Fire & Casualty Co. v. Chrysler Corp., 37 Ohio St.3d 1 (1988) (the defect question and causation standards in Ohio product liability)
- Boroff v. Aha Corp., 685 F. Supp. 2d 704 (N.D. Ohio 2010) (design defect pleading sufficiency under Ohio law)